Earning Releases

CVS Health Corp Earnings Report: Is it a Beat?

CVS Health Corp (CVS) reported an earnings beat for its 4th quarter, ending 12/31/2022. Earnings per share came in at $1.99, versus the expected $1.92.

The reported revenue of $83.88 billion represents growth of 3.22% compared to the previous quarter, and growth of 9.70% compared to the same period last year.

For the 1st quarter, analysts project earnings of $2.22 per share.

Often, earnings announcements affect a stock’s price. See a history of earnings-related price changes for CVS stock.

What’s Next for CVS Health Corp, Post-Earnings?

According to TipRanks, the average analyst consensus on CVS stock is a Strong Buy. This consensus is based on 9 analyst ratings made in the past 3 months. CVS Health Corp’s average price target of $116.25 implies upside potential of 30.68% from current levels.

See our Earnings Calendar for a full list of this week’s earnings releases.

Bottom Line

An earnings beat can signify positive movement ahead for a stock’s price. Currently, CVS price is $88.96, indicating a 5-day rise of 3.72%.

About CVS Health Corp

Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands..

Learn more about CVS financials here

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More